GeoVax Labs, Inc. is a clinical stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara Virus Like Particle MVA VLP vaccine platform. Our current development programs are focused on preventive vaccines against HIV, Zika virus, Hemorrhagic Fever viruses Ebola, Sudan, Marburg, Lassa , and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. Our vaccine platform supports in vivo production of non infectious VLPs in the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the ijmmune system to recognize, prevent, and control the target infection.
Quote | GeoVax Labs Inc. (OTCMKTS:GOVX)
Last: | $0.2678 |
---|---|
Change Percent: | -7.66% |
Open: | $0.29 |
Close: | $0.2678 |
High: | $0.29 |
Low: | $0.25 |
Volume: | 409,289 |
Last Trade Date Time: | 09/24/2020 04:53:47 pm |
News | GeoVax Labs Inc. (OTCMKTS:GOVX)
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA - ( NewMediaWire ) - April 04, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced...
ATLANTA, GA - ( NewMediaWire ) - March 28, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-...
Message Board Posts | GeoVax Labs Inc. (OTCMKTS:GOVX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $GOVX News Article - GeoVax Announces Presentation of Preliminary Data from Clinical Tr | whytestocks | investorshangout | 04/06/2023 3:25:47 PM |
whytestocks: $GOVX News Article - GeoVax to Participate at the World Vaccine Congress with Multiple | whytestocks | investorshangout | 03/30/2023 6:00:51 PM |
Lol | CarlCarlMcB | investorshub | 03/26/2023 11:33:30 PM |
Three months with no fundamental change, the elastic | XenaLives | investorshub | 03/26/2023 11:32:57 PM |
whytestocks: $GOVX News Article - GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine In | whytestocks | investorshangout | 03/15/2023 2:10:46 PM |
News, Short Squeeze, Breakout and More Instantly...
GeoVax Labs Inc. Company Name:
GOVX Stock Symbol:
OTCMKTS Market:
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA, April 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs...
Presentation Made During the 24th Annual World Vaccine Congress ATLANTA, GA - ( NewMediaWire ) - April 04, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced...
ATLANTA, GA - ( NewMediaWire ) - March 28, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chief Scientific Officer, Mark Newman, PhD, will present data on GEO-...